Pages that link to "Q5081224"
Jump to navigation
Jump to search
The following pages link to Charles Nemeroff (Q5081224):
Displaying 50 items.
- Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults (Q24649595) (← links)
- Persistent anxiolytic affects after chronic administration of the CRF1 receptor antagonist R121919 in rats (Q30467178) (← links)
- Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene (Q30483293) (← links)
- Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study (Q30717215) (← links)
- Hippocampal abnormalities in depression (Q31143469) (← links)
- Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. (Q33716733) (← links)
- Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine (Q34039450) (← links)
- Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions (Q34062101) (← links)
- Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms (Q34076744) (← links)
- Pharmacology of valproate (Q34277553) (← links)
- CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder (Q34431402) (← links)
- Asymmetrical Contribution of Brain Structures to Treatment-Resistant Depression As Illustrated by Effects of Right Subgenual Cingulum Stimulation (Q34622178) (← links)
- Thyrotropin—releasing hormone and amphetamine: A comparison of pharmacological profiles in animals (Q34877169) (← links)
- Neurochemical alterations of serotonergic neuronal systems in depression (Q35235369) (← links)
- A commentary on methods in peptide neurobiology: focus on neurotensin (Q35477166) (← links)
- Overview of the safety of citalopram (Q35560979) (← links)
- Neuropharmacology of paroxetine (Q35562763) (← links)
- The neurobiology of bipolar disorder (Q35576976) (← links)
- Are mood disorders and obesity related? A review for the mental health professional. (Q35783981) (← links)
- New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor (Q36232186) (← links)
- The neurobiology of neurotensin: focus on neurotensin-dopamine interactions (Q36466127) (← links)
- 5 Neuropeptides and neurotransmitters in Alzheimer's disease: focus on corticotrophin releasing factor (Q36495570) (← links)
- Neurotransmitters and Neuropeptides in Alzheimer's Disease (Q36501962) (← links)
- Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs (Q36515455) (← links)
- Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans (Q36713357) (← links)
- Physiology and pharmacology of corticotropin-releasing factor (Q36923875) (← links)
- Neurobiological and psychiatric consequences of child abuse and neglect (Q37794896) (← links)
- Reduced hypothalamic content of immunoreactive LH-RH-like activity in genetically obeseob/ob mice (Q38358195) (← links)
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. (Q38395078) (← links)
- Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study (Q38395700) (← links)
- Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin (Q39109781) (← links)
- Lack of effect of chronically administered thyrotropin-releasing hormone (TRH) on regional rat brain tyrosine hydroxylase activity (Q39156958) (← links)
- Pharmaco-behavioral effects of hypothalamic peptides in animals and man: focus on thyrotropin-releasing hormone and neurotensin (Q39244710) (← links)
- Models of Neuroendocrine Regulation: Use of Monosodium Glutamate as an Investigational Tool (Q39274571) (← links)
- Pharmaco-behavioral effects of oligopeptides endogenous to brain (Q39625437) (← links)
- Centrally administered neurotensin: activity in the Julou-Courvoisier muscle relaxation test in mice (Q39654721) (← links)
- Neurotensin: distribution of hypothermic response in mammalian and submammalian vertebrates (Q39709683) (← links)
- Neurotensin, a biologically active peptide (Q39780879) (← links)
- Neurotoxic amino acids and structurally related analogs (Q39781237) (← links)
- The role of hormones in depression (Q39861459) (← links)
- Comparison of the analeptic potency of TRH, ACTH 4–10, LHRH, and related peptides (Q40043496) (← links)
- The manifold actions of neurotensin: a first synthesis (Q40089813) (← links)
- Anatomy and Mechanisms of Neurotensin‐Dopamine Interactions in the Central Nervous System (Q40444515) (← links)
- Women at risk for postpartum-onset major depression (Q40465599) (← links)
- RU486 in depression (Q41085460) (← links)
- Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment (Q41089455) (← links)
- Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome (Q41101498) (← links)
- Adrenal gland enlargement in major depression. A computed tomographic study (Q41118597) (← links)
- Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802 (Q41126916) (← links)
- Role for Brain Corticotropin-Releasing Factor in the Weight-Reducing Effects of Chronic Fenfluramine Treatment in Rats* (Q41129309) (← links)